Terapia antiblastica per via intrarteriosa del carcinoma della mammella

Translated title of the contribution: Intra-arterial antiblastic treatment of breast carcinoma

Rigoantonio Roversi, Giuseppe Rossi, Stefano Ricci, Marina Roversi, Gianluigi Pinelli, Giovanna Cavallo

Research output: Contribution to journalArticlepeer-review


Purpose. To report our personal experience with the locoregional treatment of breast cancer. Material and methods. Eighteen patients aged 33-67 years (mean: 54 years) were treated with 31 sessions of intra-arterial antiblastic infusion, 5 of them for neoadjuvant purposes (Group 1), 5 for palliation in unresectable tumors (Group 2) and 8 for cutaneous recurrences after mastectomy (Group 3). Results. 2/5 CR and 3/5 PR were obtained in Group 1; 2/5 lesions were made resectable and 3/5 RP obtained in stage III or unresectable lesions (Group 2). Finally, 3/8 CR, 3/8 PR, 1/8 SD and 1/8 PD were observed in Group 3. An objective response according to WHO criteria was demonstrated in 15/18 cases (88%). We had no post-treatment hematologic complications, but one patient presented focal subcutaneous sclerosis and one cutaneous necrosis. Conclusions. The morphological efficacy of intraarterial antiblastic infusion in our series was similar to that of other series. No definitive conclusions can be drawn yet about clinical results and long-term survival. This poorly invasive and low risk procedure, which should be combined with other treatments, permits to reduce the extent of surgery and to treat skin recurrences.

Translated title of the contributionIntra-arterial antiblastic treatment of breast carcinoma
Original languageItalian
Pages (from-to)211-216
Number of pages6
JournalRadiologia Medica
Issue number3
Publication statusPublished - Mar 1998

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Intra-arterial antiblastic treatment of breast carcinoma'. Together they form a unique fingerprint.

Cite this